why choose us

First received: April 12, 2023

Clinical Trial: A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Seasonal Influenza

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2, Randomized, Open-Label Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy

Brief Summary: The purpose of this study is to measure the safety and the immune response to 3 next-generation influenza vaccine candidates (mRNA-1011.1, mRNA-1011.2,and mRNA-1012.1)compared with influenza vaccine candidate mRNA-1010 controls in healthy adult participants.

Read more